Literature DB >> 12509415

Cisplatin induces endoplasmic reticulum stress and nucleus-independent apoptotic signaling.

Aleksandra Mandic1, Johan Hansson, Stig Linder, Maria C Shoshan.   

Abstract

DNA damage is believed to be the main cause of the antiproliferative effect of cisplatin, a cornerstone agent in anticancer therapy. However, cisplatin can be expected to react also with nucleophiles other than DNA. Using enucleated cells (cytoplasts) we demonstrate here that cisplatin-induced apoptotic signaling may occur independently of DNA damage. Cisplatin-induced caspase-3 activation in cytoplasts required calcium and the activity of the calcium-dependent protease calpain. It is known that calpain activation may be associated with endoplasmic reticulum (ER) stress, suggesting that the ER is a cytosolic target of cisplatin. Consistent with this hypothesis, cisplatin induced calpain-dependent activation of the ER-specific caspase-12 in cytoplasts as well as in intact cells. Cisplatin also induced increased expression of Grp78/BiP, another marker of ER stress. By contrast, the DNA-damaging topoisomerase II inhibitor etoposide did not induce apoptotic signaling in cytoplasts nor ER stress in intact cells. We have thus identified a novel mechanism of action of cisplatin. The results have implications for the understanding of resistance mechanisms as well as the unique efficiency of this drug.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12509415     DOI: 10.1074/jbc.M210284200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  136 in total

1.  Association of active caspase 8 with the mitochondrial membrane during apoptosis: potential roles in cleaving BAP31 and caspase 3 and mediating mitochondrion-endoplasmic reticulum cross talk in etoposide-induced cell death.

Authors:  Dhyan Chandra; Grace Choy; Xiaodi Deng; Bobby Bhatia; Peter Daniel; Dean G Tang
Journal:  Mol Cell Biol       Date:  2004-08       Impact factor: 4.272

2.  Global phosphoproteome profiling reveals unanticipated networks responsive to cisplatin treatment of embryonic stem cells.

Authors:  Alex Pines; Christian D Kelstrup; Mischa G Vrouwe; Jordi C Puigvert; Dimitris Typas; Branislav Misovic; Anton de Groot; Louise von Stechow; Bob van de Water; Erik H J Danen; Harry Vrieling; Leon H F Mullenders; Jesper V Olsen
Journal:  Mol Cell Biol       Date:  2011-10-17       Impact factor: 4.272

3.  Identification by functional cloning from a retroviral cDNA library of cDNAs for ribosomal protein L36 and the 10-kDa heat shock protein that confer cisplatin resistance.

Authors:  Ding-Wu Shen; Xing-Jie Liang; Toshihiro Suzuki; Michael M Gottesman
Journal:  Mol Pharmacol       Date:  2006-01-04       Impact factor: 4.436

4.  Induction of lysosomal membrane permeabilization by compounds that activate p53-independent apoptosis.

Authors:  Hamdiye Erdal; Maria Berndtsson; Juan Castro; Ulf Brunk; Maria C Shoshan; Stig Linder
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-23       Impact factor: 11.205

5.  Cytoplasmic initiation of cisplatin cytotoxicity.

Authors:  Fang Yu; Judit Megyesi; Peter M Price
Journal:  Am J Physiol Renal Physiol       Date:  2008-04-09

6.  The soluble metal-binding domain of the copper transporter ATP7B binds and detoxifies cisplatin.

Authors:  Nataliya V Dolgova; Doug Olson; Svetlana Lutsenko; Oleg Y Dmitriev
Journal:  Biochem J       Date:  2009-04-01       Impact factor: 3.857

Review 7.  Mechanisms of Cisplatin-Induced Acute Kidney Injury: Pathological Mechanisms, Pharmacological Interventions, and Genetic Mitigations.

Authors:  Kristen Renee McSweeney; Laura Kate Gadanec; Tawar Qaradakhi; Benazir Ashiana Ali; Anthony Zulli; Vasso Apostolopoulos
Journal:  Cancers (Basel)       Date:  2021-03-29       Impact factor: 6.639

8.  Enhancement of cisplatin [cis-diammine dichloroplatinum (II)] cytotoxicity by O6-benzylguanine involves endoplasmic reticulum stress.

Authors:  Cara A Rabik; Melissa L Fishel; Julianne L Holleran; Kristen Kasza; Mark R Kelley; Merrill J Egorin; M Eileen Dolan
Journal:  J Pharmacol Exp Ther       Date:  2008-07-29       Impact factor: 4.030

9.  Synergistic interaction between cisplatin and PARP inhibitors in non-small cell lung cancer.

Authors:  Judith Michels; Ilio Vitale; Laura Senovilla; David P Enot; Pauline Garcia; Delphine Lissa; Ken A Olaussen; Catherine Brenner; Jean-Charles Soria; Maria Castedo; Guido Kroemer
Journal:  Cell Cycle       Date:  2013-02-21       Impact factor: 4.534

10.  Activation of unfolded protein response protects osteosarcoma cells from cisplatin-induced apoptosis through NF-κB pathway.

Authors:  Mingming Yan; Jiangdong Ni; Deye Song; Muliang Ding; Jun Huang
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.